GlassScriptPhysician profile
Ranjit R Singh
NPI 1326097031
$18,352.49
in general payments reported to CMS, 2019-2025
9 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2021: $23.86 · 2022: $2,498 · 2023: $236 · 2024: $1,105 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,100 · Food and Beverage: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,100.00 |
| Food and Beverage | $426.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,007.75 | 2019-2024 | |
| Medical Device Business Services, INC. | $3,892.31 | 2019-2022 | |
| Gyrus Acmi, INC. | $1,100.00 | 2024 | |
| W. L. Gore & Associates, INC. | $1,005.26 | 2022 | |
| Ethicon US, LLC | $572.98 | 2019-2025 | Vistaseal, Dermabond |
| Endogastric Solutions, INC | $553.50 | 2021-2023 | Esophyx |
| Merit Medical Systems INC | $147.52 | 2025 | Esophyx |
| Pfizer INC. | $48.93 | 2022-2023 | |
| Micro-Tech Endoscopy USA, INC. | $24.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranjit Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.